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To infect plants, Pseudomonas syringae pv. tomato
delivers 30 type III effector proteins into host cells,
many of which interfere with PAMP-triggered immu-
nity (PTI). One effector, AvrPtoB, suppresses PTI
using a central domain to bind host BAK1, a kinase
that acts with several pattern recognition receptors
to activate defense signaling. A second AvrPtoB
domain binds and suppresses the PTI-associated
kinase Bti9 but is conversely recognized by the pro-
tein kinase Pto to activate effector-triggered immu-
nity. We report the crystal structure of the AvrPtoB-
BAK1 complex, which revealed structural similarity
between these two AvrPtoB domains, suggesting
that they arose by intragenic duplication. The BAK1
kinase domain is structurally similar to Pto, and a
conserved region within both BAK1 and Pto interacts
with AvrPtoB. BAK1 kinase activity is inhibited by
AvrPtoB, and mutations at the interaction interface
disrupt AvrPtoB virulence activity. These results
shed light on a structural mechanism underlying
host-pathogen coevolution.
INTRODUCTION
Animals and plants defend themselves against potential
pathogens by detecting non-self molecules known as
pathogen/microbe-associated molecular patterns (PAMPs/
MAMPs). These conserved microbial components are perceived
by pattern recognition receptors (PRRs) leading to activation of
an immune response (Ronald and Beutler, 2010). In plants, this
layer of innate immunity is referred to as PAMP-triggered immu-
nity (PTI) and results in the production of antimicrobial com-
pounds, reactive oxygen species, fortification of the plant cell
wall, and ultimately pathogen arrest (Chisholm et al., 2006).
A well-studied PTI response in plants involves recognition
of the bacterial PAMP, flagellin, by its cognate PRR, FLS2616 Cell Host & Microbe 10, 616–626, December 15, 2011 ª2011 Els(Gomez-Gomez and Boller, 2000). FLS2 is a leucine-rich
repeat-containing receptor-like kinase (LRR-RLK) that binds
flagellin at the plant plasmamembrane, leading to its association
with the regulatory protein BAK1, phosphorylation of the cyto-
plasmic kinases BIK1 and PBL1, activation of MAP kinase sig-
naling, and transcriptional regulation of downstream genes (He
et al., 2006; Lu et al., 2010; Schulze et al., 2010; Shan et al.,
2008; Zhang et al., 2010). BAK1 is a conserved member of the
SERK family of LRR-RLKs and was originally identified as a
component of brassinosteroid (BR) signaling, specifically as a
regulator of the BR receptor, BRI1 (Clouse, 2011). In addition
to its roles in BR and flagellin signaling, BAK1 serves as a regu-
lator for EFR, a PRR that recognizes bacterial elongation factor
Tu, and is also involved in PTI responses to csp22, HrpZ, pepti-
doglycan, and lipopolysaccharide, highlighting its broad impor-
tance in immunity (Heese et al., 2007; Segonzac and Zipfel,
2011; Shan et al., 2008; Zipfel et al., 2006). Interestingly, the
dual roles of BAK1 in BR signaling and PTI are separable,
as demonstrated by the identification of a mutant allele in
Arabidopsis (Schwessinger et al., 2011).
Elucidation of the function of BAK1 in PTI was mostly accom-
plished using the Arabidopsis-Pseudomonas syringae pathosys-
tem. While the bacterial pathogen P. syringae pv. tomato strain
DC3000 (Pst) has multiple PAMPs that reveal its presence to
the plant surveillance system, it also injects30 effector proteins
through its type three secretion system into the plant cell. Collec-
tively, these effectors suppress PTI to the benefit of the bacteria
that reside in the intercellular spaces of the leaf, resulting in their
multiplication and the onset of disease (Cunnac et al., 2009).
AvrPtoB is a well-studied Pst effector with an N-terminal region
(amino acids 1–387) that interacts with the kinase domain of
BAK1 and FLS2 and suppresses signaling following flagellin
perception (Gohre et al., 2008; Shan et al., 2008). The C-terminal
E3 ligase domain of AvrPtoB may facilitate degradation of FLS2
(Gohre et al., 2008). A shorter fragment, AvrPtoB1-307, is unable
to suppress BAK1/FLS2 but interacts and interferes with another
PTI-associated kinase, Bti9/CERK1 (Figure 1A) (Gimenez-Ibanez
et al., 2009; He et al., 2006; Shan et al., 2008; Zeng et al., 2011).
AvrPtoB1-387 also enhances Pst virulence in susceptible tomato
plants (Xiao et al., 2007b), likely by targeting BAK1. Consistentevier Inc.
Figure 1. AvrPtoB250-359 Is Sufficient for Interac-
tion with the BAK1 Kinase Domain
(A) A schematic diagram of the structural organization of
AvrPtoB. T3S, type III secretion sequence; PID, Pto-in-
teracting domain; BID, BAK1-interacting domain; E3 Ub,
E3 ubiquitin ligase.
(B) The upper panel depicts the AvrPtoB fragments tested
for interaction with BAK1-KD (residues 250–591). Each
AvrPtoB fragment was individually incubated with BAK1-
KD and subjected to gel filtration analysis. Aliquots of the
peak fraction corresponding to BAK1-KD were visualized
by Coomassie blue staining following SDS-PAGE, as
observed in the lower panel.
(C) Quantification of binding affinity between BAK1-KD
and BID by isothermal titration calorimetry (ITC). Twenty-
four injections of AvrPtoB250-359 solution were added to
the BAK1-KD protein solution in the ITC cell. The area of
each injection peak corresponds to the total heat released
for that injection. The integrated heat is plotted against the
molar ratio of AvrPtoB250-359 added to BAK1-KD in the
cell. Data fitting revealed a binding affinity of 3.5 mM.
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early in the infection process and is required for the growth-
promoting and symptom-enhancing activities of other effectors
(Cunnac et al., 2011). Furthermore, homologs of avrPtoB are
present in many sequenced P. syringae strains, in line with its
important virulence function (O’Brien et al., 2011).
In addition to PTI, plants have a second layer of defense
termed effector-triggered immunity (ETI), which involves the
direct or indirect perception of effectors, typically resulting in
complete halting of the infection (Chisholm et al., 2006). The
same region of AvrPtoB that is required for its interaction with
BAK1 and PTI suppression is recognized by the tomato resis-
tance (R) protein Fen, activating ETI (Figure 1A) (Abramovitch
et al., 2003; Rosebrock et al., 2007). Another tomato R protein,
Pto, activates ETI by recognizing the region of AvrPtoB that
binds Bti9/CERK1 (Gimenez-Ibanez et al., 2009; Zeng et al.,
2011). Like BAK1 and Bti9/CERK1, both Fen and Pto are
kinases. However, the R proteins lack transmembrane and
extracellular LRR domains and require a nucleotide binding-
LRR (NB-LRR) protein, Prf, for function (Abramovitch et al.,
2003; Kim et al., 2002). Based on their similarity to the virulence
targets of AvrPtoB, it has been proposed that proteins like Pto
and Fen are molecular mimics of host virulence targets to acti-
vate ETI (van der Hoorn and Kamoun, 2008; Xing et al., 2007).
The AvrPtoB E3 ubiquitin ligase domain ubiquitinates and
thereby facilitates degradation of Fen (Abramovitch et al.,
2006; Janjusevic et al., 2006; Rosebrock et al., 2007). Interest-
ingly, Pto is able to resist this ubiquitination possibly by phos-
phorylating the C-terminal region of AvrPtoB (Ntoukakis et al.,
2009; Rosebrock et al., 2007).
Previously, a structural analysis of AvrPtoB121-205 in complex
with the Pto kinase shed light on ETI activation in tomato
(Dong et al., 2009). Here we define the domain of AvrPtoB
(AvrPtoB250-359) that interacts with BAK1 and report the crystal
structure of the AvrPtoB250-359-BAK1 complex. Structural anal-
ysis elucidated the mechanism of AvrPtoB-mediated suppres-Cell Host &sion of PTI. Surprisingly, the structure of AvrPtoB250-359 has
significant similarity to AvrPtoB121-205, likely due to an ancient
intragenic duplication. Structure-based mutagenesis and func-
tional studies confirmed the structural predictions and indicate
that AvrPtoB250-359 interferes with BAK1 by inhibiting its kinase
activity. These observations are discussed in light of the possible
evolutionary history between tomato and Pst.
RESULTS
Biochemical Characterization of the AvrPtoB-BAK1
Interaction
AvrPtoB 1-387, but not AvrPtoB1-307, interactswith theBAK1kinase
domain, indicating that the C-terminal portion of AvrPtoB1-387
is important for the association of these proteins (Figure 1A)
(Shan et al., 2008). To determine the BAK1-interacting domain
(BID) of AvrPtoB and facilitate structural analysis of the AvrPtoB-
BAK1 complex, we purified the BAK1 kinase domain (amino acids
250–591, hereafter BAK1-KD) and investigated its interaction
with AvrPtoB fragments by gel filtration. A C-terminal region,
AvrPtoB250-380, comigrated with BAK1-KD, indicating that they
form a stable complex (Figure 1B). Removal of 16 residues
from the N terminus of this fragment (AvrPtoB276-380) caused
a loss of interaction with BAK1-KD. In contrast, a C-terminal dele-
tionof 21 residues (AvrPtoB250-359) didnot affect its interactionwith
BAK1-KD. This defined a minimal BID as AvrPtoB250-359.
Isothermal titration calorimetry (ITC) showed that AvrPtoB250-359
and BAK1-KD interact with a dissociation constant of 3.5 uM,
providing further evidence that these proteins form a stable
complex (Figure 1C).
To understand the molecular mechanisms underlying the
BAK1-KD-AvrPtoB250-359 interaction, we determined the crystal
structure of the complex. The correct stoichiometry of the
complex was obtained by passing a mixture of the two purified
proteins through size exclusion chromatography and har-
vesting the peak fractions corresponding to the complex forMicrobe 10, 616–626, December 15, 2011 ª2011 Elsevier Inc. 617
Figure 2. AvrPtoB250-359 Is a Structural Homolog of
AvrPtoB121-205
(A) BID is composed of a four-helix bundle.
(B) Structural superimposition of AvrPtoB121-205 (salmon)
and AvrPtoB250-359 (light yellow). The structural elements
are labeled.
(C) Primary sequence alignment of AvrPtoB121-205 and
AvrPtoB250-359. Identical amino acids are highlighted in
red. Asterisks indicate amino acids involved in the inter-
action and mutated in subsequent experiments. R271/
R275 (green asterisks) were mutated together, whereas as
the others were mutated individually (see also Figure S1).
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molecular replacement using the coordinates of Pto as the initial
searching model for BAK1 (see Table S1, available with this
article online). Four complex molecules exist in the crystallo-
graphic asymmetric unit. The structures of the four complex
molecules in one asymmetric unit are nearly identical, with amax-
imum root-mean-square deviation (rmsd) of 0.66 A˚ between
two complex molecules. The structure of the BAK1-KD-
AvrPtoB250-359 complex was refined to a resolution of 2.5 A˚,
with an R factor and an Rfree of 18.5% and 23.8%, respectively.
AvrPtoB250-359 Is Homologous to the Pto Interaction
Domain, AvrPtoB121-205
The structure of AvrPtoB250-359 bound to BAK1-KD consists
of four a helices forming a globular helix bundle (Figure 2A).
The helices were designated aA, aB, aC, and aE, from the N
to the C terminus, following the structural nomenclature of
AvrPtoB121-205 (Dong et al., 2009).
We used DALI (Holm and Rosenstro¨m, 2010) to identify struc-
tural homologs of AvrPtoB250-359. Unexpectedly, the structure of
the BID was found to be most similar to the Pto-interacting
domain (PID) of AvrPtoB (AvrPtoB121-205), with a Z score of 7.0618 Cell Host & Microbe 10, 616–626, December 15, 2011 ª2011 Elsevier Inc.and an rmsd of 2.2 A˚ over 66 Ca atoms. In addi-
tion to the four helices, the BID has an extended
loop between aC and aE, similar to that
observed in the PID (Figure 2B). One striking
difference, however, is that aA of the BID is
much longer than aA in the PID. Despite these
similarities, the two AvrPtoB domains interact
with their respective host kinases in different
orientations (see the Discussion). A structure-
based primary sequence alignment indicated
that the two domains of AvrPtoB share only
20% amino acid identity and 38% nucleotide
identity (Figure 2C and Figure S1). The con-
served amino acids are largely hydrophobic
and are involved in the formation of the four-
helix bundle. These results suggest that the
BID and PID of AvrPtoB are evolutionarily
related, probably having derived from a com-
mon ancestral DNA sequence.
Structural Analysis of the Complexed
BAK1 Kinase Domain
The BAK1-KD has the canonical fold of protein
kinases (Figure 3A and Table S1), with a smallN-terminal lobe and a larger C-terminal lobe. As defined by
DALI, the active form of Pto and IRAK4 were the closest struc-
tural homologs of BAK1-KD, with an rmsd of 2.1 A˚ (over 260
Ca atoms) and 2.2 A˚, respectively (Figure 3A). All three are RD
kinases, whereas many other immunity-associated kinases in-
cluding FLS2, EFR, and IRAK1 are non-RD kinases (Ronald
and Beutler, 2010). The activation segment of BAK1-KD, flanked
by the DFG and APE motifs, is well defined in the structure and
adopts a similar conformation to those of Pto and IRAK4, sug-
gesting BAK1-KD in the complex assumes an active conforma-
tion. Activation of a serine/threonine kinase is usually regulated
by phosphorylation of serines or threonines within the activation
segment. Indeed, electron density showed that three residues in
this region, BAK1T446, T449, T450, are phosphorylated (Figure 3B).
Phosphorylation of these residues has previously been observed
both in vitro and in vivo (Wang et al., 2008). The phosphorylated
residue T450 (pBAK1T450) appears to be important to maintain
BAK1 in the active conformation, as the phosphate forms salt
bridges with BAK1R415, R453, K439 (Figure 3C). In contrast,
pBAK1T449 points outward to the solvent region and forms
a BAK1H447-mediated interaction with pBAK1T446. Structural
comparisons revealed that, except for Pto and IRAK4, all top
Figure 3. BAK1-KDBound byAvrPtoB250-359
Is in an Active Conformation
(A) Structural comparison of BAK1-KD, Pto, and
IRAK4. The coordinates of active Pto and IRAK4
were used for structural superimposition. The
secondary structural elements in BAK1-KD are
labeled. ‘‘N’’ and ‘‘C’’ represent the N termini and
C termini, respectively. The color codes are as
indicated.
(B) The activation segment of BAK1-KD adopts
a similar conformation to those of Pto and IRAK4.
Shown is superimposition of BAK1-KD, Pto, and
IRAK4 activation segments. The electron density
(2Fo–Fc) contoured at 1.2 s around the activation
segment of BAK1-KD is shown. The phosphory-
lated residues are displayed as sticks, and those
from BAK1-KD are labeled.
(C) The phosphate group of pT450 in BAK1-KD
forms ionic interactions with its neighboring basic
residues.
(D) The conserved ‘‘tyrosine gate’’ in BAK1-KD
and IRAK4 has a similar conformation. Shown is
a close-up view of the structural comparison
between BAK1-KD and IRAK4 around BAK1Tyr363.
The side chains from BAK1-KD and IRAK4 are
shown in orange and pink, respectively. Residues
labeled are from BAK1-KD (see also Table S1).
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Pseudomonas AvrPtoB Interaction with BAK1matches with rmsd less than 2.5 A˚ (over 250 Ca atoms) are
tyrosine kinases. Tyrosine-262 in IRAK4, termed the tyrosine
gatekeeper and shown to be critical for selection of various
kinase inhibitors, is a unique feature of the IRAK family of kinases
(Wang et al., 2006). This residue is conserved in the BAK1-KD
structure (Y363; Figure 3D), indicating that BAK1 is a member
of the IRAK family of kinases, although the residue is not impor-
tant for BAK1 kinase activity (Oh et al., 2010).
Analysis of Contact Surfaces between BAK1-KD
and AvrPtoB250-359
The BAK1-KD-AvrPtoB250-359 complex assumes a compact
globular structure (Figures 4A). In crystals, the interaction of
these two proteins results in a 1:1 stoichiometric complex,
consistent with the ITC data (Figure 1C). Analysis of the inter-
faces by PISA showed the AvrPtoB250-359-BAK1-KD complex
is stable in solution; the buried surface area upon complex
formation is 2740 A˚2 (Figure S2). Three interfaces are present
in the complex (Figure 4A). Dominating the first interface is
binding of the loop linking aC and aE (referred to as the P+1-
interacting loop) in AvrPtoB250-359 to the catalytic cleft of
BAK1-KD located at the junction of the N- and C-terminal lobes
through contacts in the P+1 loop. Additional interactions around
this interface include packing of one end of aG immediately
preceding the P+1 loop against the N-terminal side of aE in
AvrPtoB250-359. The N-terminal portion of aA together with the
N-terminal extension in AvrPtoB250-359 wedges between aC
and the N-terminal side of the activation segment, resulting in
formation of the second interface. The third interface involves
contacts of aB of AvrPtoB250-359 with aG and aI of BAK1-KD.
Interactions in the complex are established through a combi-
nation of polar and hydrophobic interactions. The first interface
is closely packed, and the P+1 loop forms backbone hydrogenCell Host &bonds with the P+1-interacting loop of AvrPtoB250-359, similar
to that observed in the AvrPto-Pto and AvrPtoB121-205-Pto
complexes (Figure 2A; Dong et al., 2009). However, unlike the
latter two complexes, in which interactions involving the P+1
loop are exclusively mediated by hydrogen bonding between
backbones, it is the side chain of BAK1R453 in the P+1 loop
that hydrogen bonds with the carbonyl oxygen of AvrPtoBV337
and the hydroxyl group of AvrPtoBS335 that hydrogen bonds
with BAK1K418 (Figure 4B). In addition to the intricate core
network of hydrogen bonds, surrounding van derWaals contacts
fortify interactions at this interface including hydrophobic con-
tacts between BAK1I456 and AvrPtoBL342, L336.
The P+1 loop of kinases is located in the region of substrate
binding where phosphorylation occurs. Our observation that
AvrPtoB250-359 directly contacts the P+1 loop of BAK1-KD
suggests AvrPtoB250-359 inhibits BAK1 kinase activity. To inves-
tigate this possibility, we tested the effects of AvrPtoB250-359 on
BAK1-KD autophosphorylation. The proteins were purified and
the kinase activity of BAK1-KD was examined in the presence
of AvrPtoB250-359. As shown previously, BAK1-KD exhibited
strong autophosphorylation (Figure 4C; Wang et al., 2008).
BAK1-KD autophosphorylation was attenuated by the addition
of AvrPtoB250-359 andwas progressively reduced with increasing
amounts of AvrPtoB250-359 (Figure 4C). AvrPtoB variants that are
unable to interact with BAK1 were unable to suppress BAK1
kinase activity (Figure S2). Notably, AvrPtoB is phosphorylated
by BAK1 in this assay, and it is possible that BAK1 contributes
to the previously reported phosphorylation of residue S258 in
AvrPtoB (Xiao et al., 2007a).
Insertion of the side chain of AvrPtoBR271 into the pocket
formed by aA of AvrPtoB and the N-terminal side of the BAK1
P+1 loop constitutes the center of the second interface (Fig-
ure 4D). AvrPtoBR271 makes van der Waals contacts withMicrobe 10, 616–626, December 15, 2011 ª2011 Elsevier Inc. 619
Figure 4. Specific Recognition of AvrPtoB
by BAK1-KD
(A) A cartoon representation of the overall
structure of the AvrPtoB250-359-BAK1-KD complex.
AvrPtoB250-359 and BAK1-KD are colored in yellow
and purple, respectively. The three interfaces, I, II,
and III, within the complex are highlighted in the red
dashed frames. The P+1 loop of BAK1-KD is indi-
cated. Someof the secondary structural elements in
the BAK1-KD are labeled. (B), (D), and (E) show the
detailed interactions of the interfaces I, II, and III in
(A), respectively.Thesidechains fromAvrPtoB250-359
and BAK1-KD are colored in orange and magenta,
respectively. Relevant amino acid residues are
numbered. Red dashed lines represent polar
interactions. (C) AvrPtoB BID inhibits BAK1-KD
kinase activity and is phosphorylated by BAK-KD
in vitro. To determine the effect of the BID on BAK1
kinase activity, BAK1-KD autophosphorylation
assayswere performed in the presence of different
concentrations of the BID (0, 2.17 mM, 4.34 mM,
8.68 mM, 17.36 mM, 119.5 mM, and 141.2 mM;
bottom panel, Coomassie blue-stained gel). All
reactions were incubated at 30 degrees for 30 min
and terminated by adding an equal volume (50 ml)
of 23 SDS buffer. SDS-polyacrylamide gel
electrophoresis was used to fractionate proteins,
and the phosphorylated BAK1 (pBAK1-KD) and
AvrPtoB (pAvrPtoB250-359) were visualized with
a phosphorimager (top panel) (see also Figure S2).
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Pseudomonas AvrPtoB Interaction with BAK1BAK1L329, R453 and also forms ionic interactions with the phos-
phate of pBAK1T450 and hydrogen bonds with BAK1T333. In
addition to AvrPtoBR271, the phosphate of pBAK1T450 forms a
pair of salts bridges with AvrPtoBR275. These observations ex-
plain why AvrPtoB276-380 does not interact with BAK1-KD. At
the periphery of this contact interface, the amide nitrogen of
AvrPtoBV269 forms a hydrogen bond with BAK1Q332, whereas
its side chain packs tightly against the Ca atom of BAK1L329.
Compared to the other two interfaces, the third inter-
face is primarily hydrophobic and less packed. Packing of
AvrPtoBV307, M308, V346 against a2 of BAK1 and a3 appears to
mainly contribute to the interactions around the interface
(Figure 4E).
Structure-Informed Mutagenesis of BAK1-KD
and AvrPtoB250-359 Disrupts the Complex
We next engineered amino acid substitutions in BAK1-KD and
evaluated their impact on the interaction with AvrPtoB250-359620 Cell Host & Microbe 10, 616–626, December 15, 2011 ª2011 Elsevier Inc.using gel filtration. Circular dichroism
experiments indicated that the sub-
stitutions did not affect the global struc-
ture of BAK1-KD (Figure S3). As a pos-
itive control, the wild-type BAK1-KD
protein formed a stable complex with
AvrPtoB250-359 (Figure 5A). In contrast,
BAK1-KD substitutions that were pre-
dicted to disrupt the first interface,
BAK1-KDI456D, L464D, resulted in a loss
of interaction with AvrPtoB250-359.
BAK1-KDA451 andBAK1-KDA495 are posi-tioned in small hydrophobic pockets at the second and third
interfaces, respectively. As expected, substitutions of these
amino acids with the bulkier, charged residue glutamic acid dis-
rupted the interaction with AvrPtoB250-359.
Our analysis above indicates that BAK1-KD adopts an
active conformation in the complex. Although the residues
BAK1V452, T455, H458 are not directly involved in binding
AvrPtoB250-359, they are important for maintaining the active
conformation of the activation segment by making interactions
with their neighboring residues. As predicted, gel filtration
revealed that substitutions in these amino acids of BAK1-KD
disrupted their ability to interact with AvrPtoB250-359, suggesting
the active conformation of BAK1 is important for its inter-
action with AvrPtoB (Figure 5A). To test if phosphorylation of
BAK1T450 is required for the interaction with AvrPtoB250-359, we
made the substitution BAK1T450A, which is expected to disrupt
the ionic interaction between the phosphate group and its
surrounding basic residues at the second interface. This variant
Figure 5. Mutagenesis Analyses of AvrPtoB250-359-BAK1-KD
Complex
(A) Effects of point mutations in BAK1 on the interaction with AvrPtoB.
BAK1-KD variant proteins were individually incubated with AvrPtoB250-359 and
subjected to gel filtration. Aliquots of the peak fraction corresponding to
BAK1-KD were visualized by Coomassie blue staining following SDS-PAGE.
(B) Effects of point mutations in AvrPtoB on the interaction with BAK1. The
assay is similar to (A) except that AvrPtoB mutant proteins were used to test
interaction with wild-type BAK1-KD (see also Figure S3).
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Pseudomonas AvrPtoB Interaction with BAK1protein did not interact with AvrPtoB250-359 (Figure 5A). A T450A
substitution was previously reported to abolish the ability of
BAK1 to function in FLS2 signaling (Wang et al., 2008), reinforc-
ing the importance of this residue.
We tested the kinase activity of additional BAK1 variant
proteins and found that most of the proteins that lacked kinase
activity were also unable to interact with AvrPtoB (Figure S3).
The only exception is T449A, which had comparable kinase
activity to wild-type BAK1 but exhibited no interaction with
AvrPtoB250-359. The reason for this may be that phosphorylation
of T449 leads to its interaction with BAK1 H447 (Figure 3B),
which can play a role in maintaining proper conformation of the
P+1 loop required for interaction with AvrPtoB250-359 but not
BAK1 substrates. Although the precise mechanisms await
further investigation, our structural and biochemical data sup-
port the idea that kinase activity of BAK1 is important for its
ability to bind AvrPtoB.
To further test thecontact surfaces inferred from theBAK1-KD-
AvrPtoB250-359 structure,weusedgel filtration toassess the inter-
action between AvrPtoB250-359 variants and BAK-KD. Five vari-
ants, AvrPtoB250-359
R271A/R275A, L336R, V337R, L341R, and V346D,
were unable to interact with BAK1-KD (Figure 5B). Circular
dichroism experiments of these AvrPtoB variants indicated that
two of them (V337R and L341R) deviated from the wild-type
protein, suggesting that these substitutions disturbed the global
conformation of AvrPtoB250-359 (Figure S3). However, loss ofCell Host &BAK1-AvrPtoB250-359 interaction caused by other substitutions
in AvrPtoB250-359 as well as those in BAK1 supports the crystal
structure. In particular, mutation of AvrPtoB residues R271/
R275, which interact with the phosphate group of T450, did
not affect global AvrPtoB structure but abolished interaction
with BAK1.
Structure-Informed Functional Analysis of AvrPtoB
Residues Involved in the BAK1 Complex
To functionally test the structure, we first identified a min-
imal fragment of AvrPtoB sufficient for virulence activity. The
N-terminal 387 amino acids of AvrPtoB are known to suppress
MAPK activation in response to flg22 stimulation in Arabidopsis
protoplasts expressing a tagged version of AtMPK6, whereas
AvrPtoB1-307 cannot do so (He et al., 2006). This suppression
of MAPK activity presumably results from AvrPtoB-BAK1 inter-
action (Shan et al., 2008). To determine the minimal biologically
active fragment of AvrPtoB, we used the MAPK suppression
assay and found AvrPtoB1-359 to be sufficient forMAPK suppres-
sion and essentially equal to AvrPtoB in its activity (Figure 6A).
AvrPtoB250-359 accumulated poorly in protoplasts and did not
suppress AtMPK6 activation (data not shown).
We then assessed the contribution of amino acids identified
in the structural analysis as important for the interaction
with BAK1-KD to the biological activity of AvrPtoB1-359. Five vari-
ants of AvrPtoB1-359 were tested for their ability to suppress
AtMPK6 activation in the MAPK assay. All five variants,
AvrPtoB1-359
R271A/R275A, L336R, V337R, L341R, and V346D, were
compromised for biological function to various degrees when
compared with wild-type (Figure 6A), although, as noted above,
the global structure of two of these variant proteins was disrup-
ted when expressed as AvrPtoB250-359 proteins, and they are
therefore less informative.
We next determined if our results from the molecular
assay were reflective of bacterial virulence in plants. Because
AvrPtoB1-359 virulence activity has not been characterized for
Pst DC3000 infection assays in Arabidopsis, we instead tested
this activity in the Pst-tomato pathosystem (Xiao et al., 2007b).
Shortened forms of AvrPtoB, lacking the E3 ubiquitin ligase
domain, are sufficient for enhancing virulence of Pst DC3000 in
susceptible tomato plants (Xiao et al., 2007b). The kinase
domains of the two proteins in tomato with closest similarity to
Arabidopsis BAK1 (SlSERK3A [GenBank accession number
HQ438098] and SlSERK3B [HQ438099]) are 95% identical to
that of AtBAK1, and all of the residues tested in Figure 5A are
identical in these two proteins. This conservation supports the
use of this pathosystem for AvrPtoB virulence assays.
We tested strains of DC3000DavrPtoDavrPtoB expressing
each of the five AvrPtoB1-359 variants under the control of a
hrp-inducible promoter for bacterial growth in susceptible
Rio Grande (RG)-prf-3 tomato plants in comparison with wild-
type AvrPtoB1-359. DC3000DavrPtoDavrPtoB strains expressing
three of the variants, AvrPtoB1-359
V337R, L341R, and V346D, were
compromised in growth in the lower leaves at 2 days post-
inoculation (Figure 6B). The difference was small but statis-
tically significant as analyzed over seven experiments. Addition-
ally, disease symptoms caused by the strains expressing
AvrPtoB1-359
V337R, L341R, and V346D were frequently but not always
attenuated on the lower leaves of the plants (Figure S4).Microbe 10, 616–626, December 15, 2011 ª2011 Elsevier Inc. 621
Figure 6. Mutant Forms of AvrPtoB1-359 Unable to Interact with
BAK1-KD In Vitro Are Impaired in Virulence
(A) AvrPtoB (ApB) variants unable to interact with BAK1-KD in vitro have
reduced ability to suppress MPK6 activation in Arabidopsis Col-0 protoplasts.
Protoplasts expressing AtMPK6 and AvrPtoB were treated with 1 mM flg22 for
10 min. AtMPK6 activity was assessed in an immunocomplex kinase assay
with MBP as the substrate (upper panel shows autoradiograph). AtMPK6 and
AvrPtoB protein abundance were detected by immunoblot analysis (middle
and lower panels). The smaller protein in the full-length AvrPtoB lane is
probably a degradation product of the effector.
(B) AvrPtoB variants unable to interact with BAK1-KD in vitro have
reduced virulence in tomato. Pst DC3000DavrPtoDavrPtoB strains expressing
AvrPtoB1-359 wild-type or its variants were vacuum infiltrated into RG-prf-3
leaves at 3 3 104 cfu/ml. Bacterial growth per leaf area was determined at
0 and 2 days postinoculation (dpi). The figure is derived from data from one
representative experiment using four biological replicates per strain. *Signifi-
cantly different from wild-type at p < 0.05. The statistical analysis was per-
formed on data derived from seven experiments, analyzed as the fold increase
between days 0 and 2, using a one-way ANOVA with Tukey’s HSD as the
correction; bars represent ± standard error (see also Figure S4 and Table S2).
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Pseudomonas AvrPtoB Interaction with BAK1Each of the AvrPtoB1-359 variants was detectable after induc-
tion in hrp-inducing conditions (Figure S4). However, consistent
with the circular dichroism data, the AvrPtoB1-359(L341R) variant
accumulated poorly, which may account for its reduced
virulence activity. The AvrPtoB1-359(V337R) protein was detected
by Pto-expressing plants, suggesting this longer form may
be less affected than the spectroscopy results with the622 Cell Host & Microbe 10, 616–626, December 15, 2011 ª2011 ElsAvrPtoB250-359 suggest. To further test protein stability and
also verify delivery from Pst, we infected RG-PtoR tomato plants
that express Pto conferring immunity to bacteria expressing
AvrPtoB1-307 with the same strains (Xiao et al., 2007b). As ex-
pected, all the strains activated immunity, with the exception of
the AvrPtoB1-359
L341R variant (Table S2A).
The domain of AvrPtoB required for interaction with BAK1-KD
overlaps with the Fen-interacting domain (Rosebrock et al.,
2007; Shan et al., 2008), and we hypothesized that some of the
AvrPtoB substitutions might also affect the interaction with
Fen. This assay would effectively test the hypothesis that Fen
acts as a molecular mimic of BAK1. The same Pst strains ex-
pressing the AvrPtoB variants were inoculated into RG-pto11
tomato plants; these plants express Fen, but have a point
mutation in Pto rendering it ineffective. Strains expressing
AvrPtoB1-359
R271A/R275A, L341R, or V346D did not activate Fen-
mediated immunity and caused disease, indicating a loss of
Fen interaction (Table S2A). Notably, this subset of variants did
not completely correlate with those that lost virulence activity
in susceptible plants. Therefore, if Fen evolved as a molecular
mimic of BAK1, it is not a perfect one, as it has structural differ-
ences in its contact surfaces with AvrPtoB.
DISCUSSION
Acting as an accessory protein to multiple PRRs, BAK1 plays
a central role in PTI signaling. The targeting of BAK1 by AvrPtoB,
then, is a particularly effective way to suppress PTI and enhance
bacterial virulence.ThemolecularmechanismsbywhichAvrPtoB
acts on BAK1 to inhibit downstream signaling, however, are
largely unknown. In order to further characterize this mechanism,
we used structural and functional analyses to examine the BAK1-
AvrPtoB interaction in relation to the virulence activity of AvrPtoB.
Two N-terminal domains of AvrPtoB interact with multiple host
kinases (Figure 1A) (Gimenez-Ibanez et al., 2009; Rosebrock
et al., 2007; Shan et al., 2008; Xiao et al., 2007b). In Arabidopsis,
AvrPtoB1-307, which encompasses the most N-terminal kinase-
binding domain (amino acids 121–205), is sufficient to interact
with the Bti9/CERK1 kinase, but not the BAK1 kinase (Gime-
nez-Ibanez et al., 2009; Shan et al., 2008; Zeng et al., 2011). In
tomato, the Pto kinase recognizes AvrPtoB121-205 to activate
immunity. The Pto familymember Fen, which shares80% iden-
tity with Pto, does not recognize AvrPtoB121-205 (Dong et al.,
2009). BAK1, Fen, and likely FLS2 require a different kinase-
binding domain (amino acids 250–359) for interaction with
AvrPtoB, although the exact domain for the interaction with
Fen and FLS2 is unknown (Gohre et al., 2008; Rosebrock
et al., 2007; Shan et al., 2008). These differential interactions
demonstrate the kinase-binding specificity of AvrPtoB.
Like AvrPtoB121-205, AvrPto, aPst effector that lacks homology
to AvrPtoB, interacts with Pto but not with Fen (Tang et al., 1996;
Xing et al., 2007). Our previous work revealed that Pto
utilizes two distinct surfaces adjacent to its P+1 loop that are
not conserved in Fen to distinguish between AvrPto and
AvrPtoB121-205 (Dong et al., 2009). This not only offers an
explanation for the inability of Fen to recognize AvrPto and
AvrPtoB121-205, but also suggests that the specificity determi-
nants within the kinase are located in the nonconserved regions
flanking the P+1 loop.evier Inc.
Figure 7. Structural Comparison and Evolutionary Model of the
AvrPtoB121-205-Pto and AvrPtoB250-359-BAK1 Complexes
(A) The AvrPtoB250-359-BAK1 complex is shown on the left and the
AvrPtoB121-205-Pto complex on the right. The BID and PID in their respective
complex have different orientations despite their similar overall structure.
(B) An evolutionary model for AvrPtoB virulence activity and host recognition.
Two possible paths are illustrated. Kinases shown in blue normally activate PTI
in response to PAMPS but are suppressed upon AvrPtoB binding. Kinases
shown in salmon activate ETI after binding to specific domains of AvrPtoB. The
AvrPtoB E3 ligase ubiquitinates Fen to overcome ETI (Rosebrock et al., 2007).
IA-RLK, immunity-associated receptor-like kinase; KID, kinase-interacting
domain; E3UL, E3 ubiquitin ligase; Ubq, ubiquitin. See the Discussion for
more detail.
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AvrPtoB250-359 interact with different host kinases, our structural
comparison revealed striking similarities between these two
domains. Interestingly, AvrPtoB121-205 and AvrPtoB250-359 bind
Pto and BAK1-KD, respectively, in different orientations (Fig-
ure 7). In order for AvrPtoB121-205 to interact with BAK1-KD, it
would have to maintain its interactions with the P+1 loop and
adopt a similar orientation to that in complex with Pto. Such
positioning of AvrPtoB121-205, however, would lead to a loss of
the contact surface governed by PtoF213 because the equivalent
amino acid, BAK1L464, is not conserved. Furthermore, substitu-
tion of PtoV51 with BAK1G295 would add additional instability to
the putative formation of AvrPtoB121-205-BAK1 complex. These
subtle structural differences likely play an important role in the
inability of AvrPtoB121-205 to interact with BAK1.
Fen and BAK1 both bind the same AvrPtoB domain (Rose-
brock et al., 2007; Shan et al., 2008). Here we delimit the BID
to AvrPtoB250-359. We hypothesize that this smaller regionCell Host &also interacts with Fen, but this remains to be tested ex-
perimentally. By aligning the P+1 loop of Fen and BAK1, Fen
would be expected to maintain two of the three contact
surfaces with AvrPtoB250-359. The amino acids that are involved
in the interaction with AvrPtoB250-359 at the first interface,
BAK1K418, R453, I456, are conserved in Fen. Compared to
AvrPtoB121-205, AvrPtoB250-359 possesses an N-terminal exten-
sion that is directly involved in binding BAK1-KD at the second
interface, mainly through polar interactions with the phosphate
of BAK1pT450. The equivalent amino acid, T197, is conserved in
Fen, although its phosphorylation status is unknown. Additional
residues around the second interface involved in interaction
with AvrPtoB250-359, including BAK1
R453 and BAK1T333, are
also conserved in Fen. Thus the N-terminal extension of
AvrPtoB250-359 is expected to bind the second interface of Fen,
which may compensate for the predicted compromised inter-
action around the third interface caused by variations of residues
from a2 and a3 of Fen.
We found that AvrPtoB250-359 functions as an inhibitor of the
BAK1 kinase in vitro, most likely by competitive interference at
the substrate-binding site. Whether this inhibition occurs when
AvrPtoB is delivered into the plant cell by Pst is unknown.
However, several bacterial effector proteins are known to inhibit
the activity of host kinases (Li et al., 2007; Xiang et al., 2008;
Xing et al., 2007; Zhang et al., 2010). In most cases, the effec-
tors require enzymatic activity for inhibition, permitting each
effector molecule to act on multiple kinase molecules after
delivery into the host. In the case of AvrPtoB, its only known
enzymatic domain is an E3 ubiquitin ligase, but this activity is
dispensable for the inhibition of BAK1 kinase activity and also
for virulence in the natural host-pathogen system (Shan et al.,
2008; Xiao et al., 2007a; Zeng et al., 2011). Thus a one-to-one
correlation of AvrPtoB molecules to specific host kinases would
be needed to inactive them. This is plausible if we consider
immune responses to invading bacteria to be extremely local-
ized. AvrPtoB would be delivered at an early time point into
the plant cell and bind to and paralyze each activated immune
kinase encountered in the vicinity of the point of delivery. Other
effectors would then be delivered to suppress additional host
components of PTI, eventually leading to disease. AvrPto has
also been shown to inhibit kinase activity despite its lack of
characterized enzymatic activity (Xiang et al., 2008; Xing
et al., 2007). Our understanding of kinase inhibition by AvrPto
and AvrPtoB may become clearer as the temporal delivery
and spatial distribution of these proteins within the host cell
becomes known.
Structural analyses directed our attention to six amino acids
in AvrPtoB that when mutated would be likely to disrupt the
interaction with BAK1 and abolish the virulence activity of
AvrPtoB1-359. Introduction of substitutions at these residues
disrupted the in vitro interaction between AvrPtoB250-359 and
BAK1-KD. These substitutions also largely reduced the ability
of AvrPtoB1-359 to suppress MPK6 activation. However, when
delivered from Pst, only three of the AvrPtoB1-359 variants
led to a statistically significant decrease in bacterial growth
compared with the wild-type protein. One of the three,
AvrPtoB1-359
L341R, was poorly expressed and led to global
destabilization of AvrPtoB250-359, providing an explanation for
its reduced virulence activity.Microbe 10, 616–626, December 15, 2011 ª2011 Elsevier Inc. 623
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Pst in planta are typically small, likely due to redundancy within
the effector repertoire (Cunnac et al., 2009). Moreover, AvrPtoB
is known to interact with multiple host kinases, and it is possible
it targets additional proteins (Gimenez-Ibanez et al., 2009; Gohre
et al., 2008; Kim et al., 2002; Rosebrock et al., 2007; Shan et al.,
2008). Potentially, the AvrPtoBmutations we have tested disrupt
the interaction with a single host target, BAK1, while retaining the
ability to act on others. This may explain the minor decreases in
virulence we observed in our tomato virulence assays. Alterna-
tively, additional contacts between amino acids 1–250 of AvrP-
toB and BAK1-KD may stabilize the interaction and reduce the
effects of AvrPtoB mutations on this phenotype.
We hypothesized that in tomato Fen might have evolved as
a molecular mimic (a decoy) of BAK1 leading to ETI (van der
Hoorn and Kamoun, 2008; Xing et al., 2007). One way to test
this is to determine whether the AvrPtoB amino acids that play
a role in BAK1 interaction and virulence activity are also neces-
sary for recognition by Fen. Of the two well-expressed AvrPtoB
variants, one did not interact with BAK1 and was compromised
in all virulence phenotypes; it also was not recognized by Fen.
It is possible that Fen is a decoy, but it does not appear to be
a perfect mimic of BAK1. The existence of an ‘‘imperfect decoy’’
may be beneficial to the plant by allowing the decoy to avoid
unintended interactions with downstream components of the
PTI signaling machinery. Collectively, our analyses suggest
that AvrPtoB121-205 and AvrPtoB250-359 have evolved to target
the structurally conserved portion of kinases to inhibit their
activity, and also certain divergent structural elements to achieve
specificity for distinct kinases.
Given their lack of obvious sequence similarity, the finding that
AvrPtoB121-205 and AvrPtoB250-359 are structurally similar was
surprising. However, upon further analysis we found the two
domains share 20% amino acid identity. The proximity of the
two kinase-binding domains in AvrPtoB and presence of
sequence similarity suggest that these domains have arisen
long ago by tandem duplication of a progenitor kinase-
interacting domain (KID). Tandem duplication and divergence
is a well-known evolutionary force, and it is common for
sequences to diverge beyond the point of similarity recognition
by computational methods even though they may share the
same evolutionary origin (Chothia and Gough, 2009; Gough,
2005).
Our current model posits that AvrPtoB initially had a type III
secretion signal linked to a single KID (Figure 7B). The KID was
sufficient to suppress the activity of an immunity-associated
receptor-like kinase (IA-RLK). A progenitor of Fen evolved to
recognize this domain. There are then two evolutionary paths
that present-day AvrPtoB may have taken. The first involves
tandem duplication of the KID followed by divergence of the
duplicated domain to interact with other IA-RLKs. In order to
recognize the new virulence activity of the duplicated KID, the
Fen progenitor also sustained a duplication event leading to
the divergence of Fen and Pto (these genes are members of
a clustered gene family in tomato). Based on the widespread
occurrence of Fen-like resistance in wild relatives of tomato,
we have proposed previously that Fen evolved prior to Pto
(Rosebrock et al., 2007). A subsequent evolutionary event
leading to the present form of AvrPtoB was the acquisition of624 Cell Host & Microbe 10, 616–626, December 15, 2011 ª2011 Elsan E3 ubiquitin ligase domain. The second path may have
involved the linkage of the E3 ubiquitin ligase domain to the
single KID, followed by the tandem duplication of the KID and
divergence to interact with different IA-RLKs and Pto. Regard-
less of the evolutionary sequence, AvrPtoB has acquired unusu-
ally effective virulence domains.EXPERIMENTAL PROCEDURES
Crystallization, Data Collection, Structure Determination,
and Refinement
Details of protein expression and purification, gel filtration, and the ITC exper-
iments are described in the Supplemental Experimental Procedures. Crystal-
lization conditions for BAK1-KD in complex with AvrPtoB250-359 were initially
determined from the sparse matrix screen (Hampton Research). Screening
was performed using hanging drop vapor diffusion by combining 2 ml of protein
solution with an equal volume of well buffer. Crystals of the complex were
eventually grown in the buffer containing 0.6 M NH4Ac, 17.5% PEG3350
(v/v) at room temperature. Typically, the crystals grew to their maximum size
(0.1 3 0.2 3 0.2 mm3) within 5 days. The crystals were transferred to the
mother liquor containing an additional 25% (v/v) glycerol and flash cooled in
liquid nitrogen. The diffraction data were collected at the Shanghai Synchro-
tron Radiation Facility (SSRF) at beamline BL17U1 using a CCD detector.
The data were processed using HKL2000 (Otwinowski and Minor, 1997).
Further details of the structural analysis are described in the Supplemental
Experimental Procedures. The crystallographic data are summarized in
Table S1.Kinase Assay
The assay was performed as described (Xing et al., 2007). The reaction
buffer contained 50 mM HEPES (pH 7.4), 10 mM MgCl2, 1 mM DTT,
10 uM ATP, and 1 ul [g-32P]ATP. For autophosphorylation reactions, 0.5 mg
of BAK1-KD was added to 30 ml of reaction buffer. BAK1 was not dephos-
phorylated, as it was known from previous work (Wang et al., 2008) that
BAK1 purified from E. coli is not phosphorylated on all of its potential in
planta phosphorylation sites. The reaction mixture was incubated at 30C
for 0.5 hr and terminated by adding an equal volume of 23 SDS buffer. To
determine the effect of AvrPtoB250-359 on BAK1-KD activity, BAK1-KD auto-
phosphorylation was assayed in the presence of various concentrations
of AvrPtoB250-359: 0, 2.17 mM, 4.34 mM, 8.68 mM, 17.36 mM, 119.5 mM,
and 141.2 mM. Protein samples were separated by SDS polyacrylamide
electrophoresis, and phosphorylated proteins were visualized with a
phosphorimager.MAPK Suppression Assay
Protoplasts were prepared from 3- to 4-week-old Arabidopsis thaliana Col-0
plants grown in long day conditions with a light intensity of 70 mE/m2/s using
the Tape sandwich method followed by transformation with AtMPK6-23FLAG
and the AvrPtoB variants using the TEAMPmethod (Wu et al., 2009; Yoo et al.,
2007). MAPK suppression assays were carried out according to the methods
of He et al. (2006). Primers and plasmids used for the AvrPtoB constructs are
provided in Table S2. Further details are provided in the Supplemental Exper-
imental Procedures.AvrPtoB Virulence Assays in Tomato
AvrPtoB1-359 lacking a stop codon was cloned into the SmaI site of pJM51 for
use in the Gateway recombination system and sequence confirmed. Site-
directed mutagenesis was performed on the resulting construct to produce
the following variants of AvrPtoB1-359: R271A/R275A, L336R, V337R, L341R,
and V346D. Entry vectors containing wild-type AvrPtoB1-359 and its variants
were recombined into pCPP5372, a Gateway destination vector containing
the AvrPto hrp promoter and a C-terminal HA tag (Oh et al., 2007) via the LR
recombination reaction (Invitrogen). Virulence assays were carried out similar
to the methods of Xiao et al. (2007b). Further details are provided in the
Supplemental Experimental Procedures.evier Inc.
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